LRR11

LRR11 (PF3D7_1123200; PfLRR1) is a leucine-rich repeat protein of Plasmodium that functions as a regulator of protein phosphatase type 1 (PP1), coupling PP1 activity to cell-cycle progression and parasite development (PMID:16629662, PMID:35920043). In P. falciparum, LRR11 physically binds PfPP1 both in vitro and as a native complex in parasite extracts, and inhibits PfPP1 catalytic activity (PMID:16629662); it is one of 14 LRR-containing proteins in the parasite and is transcribed predominantly in late intraerythrocytic stages (late trophozoites and schizonts) (PMID:17689674). When expressed heterologously in Xenopus oocytes, LRR11 engages endogenous PP1 and drives G2/M progression, phenocopying PP1 inhibition and indicating that its suppression of PP1 can override the G2/M checkpoint (PMID:16629662). The P. berghei orthologue (PbLRR1) similarly complexes with and inhibits PbPP1 across asexual and sexual stages, and its depletion controls the phosphorylation status of the PP1 regulator Inhibitor 3 (I3) and impairs oocyst development in the mosquito, establishing LRR11 as a physiologically required node in the PP1 regulatory network (PMID:35920043). Beyond its role as a PP1-binding regulator, no additional catalytic or structural mechanism for LRR11 has been characterized in the available corpus.

1. 2006 High

   Establishing that LRR11 is not merely an LRR protein but a direct partner and inhibitor of PP1 defined its core biochemical function.

   Evidence GST pull-down, native parasite extract co-IP, and in vitro phosphatase assay in P. falciparum

   PMID:16629662

   Open questions at the time

   • Structural basis of the LRR11–PfPP1 interaction not resolved
   • The PP1 residue or domain contacted by LRR11 not mapped
   • Whether inhibition is competitive with substrate or regulatory subunits unknown
2. 2006 Medium

   A heterologous Xenopus oocyte system linked LRR11's PP1 inhibition to a defined cell-cycle output, showing it can override the G2/M checkpoint.

   Evidence Xenopus oocyte GVBD assay with okadaic acid and anti-PP1 antibody controls

   PMID:16629662

   Open questions at the time

   • G2/M-promoting role not directly demonstrated in the parasite cell cycle
   • Downstream cell-cycle effectors of PP1 in Plasmodium not identified
   • Heterologous system may not recapitulate parasite regulatory context
3. 2007 Medium

   Cataloguing LRR11 among the parasite's LRR proteins and profiling its stage-specific transcription placed its expression at the late intraerythrocytic stages relevant to schizogony.

   Evidence Genome-wide identification, cloning/cDNA sequencing, and RT-qPCR stage profiling in P. falciparum

   PMID:17689674

   Open questions at the time

   • Protein-level expression timing not established
   • Functional consequence of late-stage enrichment not tested
   • LRR motif contribution to PP1 binding not dissected
4. 2022 High

   Genetic depletion in P. berghei moved LRR11 from an in vitro PP1 inhibitor to an in vivo developmental requirement, and phospho-proteomics placed it upstream of Inhibitor 3 phosphorylation.

   Evidence Co-IP, in vitro phosphatase assay, conditional depletion with oocyst quantification, interactome MS and phospho-proteomics in P. berghei

   PMID:35920043

   Open questions at the time

   • Mechanism by which the PP1–LRR1 complex sets I3 phosphorylation not resolved
   • Whether I3 hypophosphorylation causes the oocyst defect not established
   • Asexual-stage essentiality of the orthologue not quantified in this readout

• How LRR11 integrates PP1 inhibition, I3 phosphorylation control, and cell-cycle/developmental timing into a single regulatory mechanism remains open.
• No structure of LRR11 alone or bound to PP1
• Direct in-parasite demonstration of G2/M control in P. falciparum absent
• Causal chain from LRR11 loss to I3 hypophosphorylation to oocyst failure not established